Craigavon, N.I., UK, - 09 November 2015 - Almac Group, the global contract development and manufacturing organisation, has confirmed a £16 million investment to expand its formulation and analytical ...

Almac is pleased to announce the expansion of our drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical ...

Almac has created a new non-GMP formulation development facility and two new analytical laboratories at their U.K. headquarters in Craigavon to expand its drug product pharmaceutical development ...

When describing their company, Almac Group managers like to employ the color-coded map of London's Underground as a visual aid. It is an apt metaphor for a firm with five drug development service ...

This investment is additional to and separate from £11 million that was announced in the fall of 2024 for creating new jobs and expanding Almac’s global analytical services capabilities. Almac ...

Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will ...

Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent ...

Almac Sciences, a member of the Almac Group, said today it has expanded its suite of analytical solutions to include biologics testing solutions. The company said its services will now include, in ...

To win at the drug development game, it’s not enough to show up with a great molecule. Many compounds would stall at the discovery stage without effective ways to get them inside patients. But the ...

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, a ...